MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 997 shares, a decline of 92.7% from the July 15th total of 13,638 shares. Based on an average daily trading volume, of 168,076 shares, the days-to-cover ratio is currently 0.0 days.
MediPharm Labs Stock Performance
Shares of OTCMKTS MEDIF traded up $0.00 during trading on Tuesday, reaching $0.05. 133,521 shares of the company traded hands, compared to its average volume of 81,943. The firm has a 50 day simple moving average of $0.05 and a 200-day simple moving average of $0.05. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.08.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
